Skip to main content
Fig. 2 | BMC Medical Genomics

Fig. 2

From: Identification of miR-143-3p as a diagnostic biomarker in gastric cancer

Fig. 2

Expression levels of 15 differentially expressed miRNAs and receiver operating characteristic curve analysis of 15 differentially expressed miRNAs of gastric cancer tissues vs. adjacent non-tumor tissues in the analysis set. miRNAs upregulated in gastric cancer were a miR-23a, b miR-34c, c miR-423, d miR-496, e miR-500b, f miR-542, g miR-1228, and h miR-3687. miRNAs downregulated in gastric cancer were i miR-30a, j miR-133a-1, k miR-133a-2, l miR-133b, m miR-139, n miR-143, and o miR-195. The area under the receiver operating characteristic curve values were calculated to estimate the diagnostic performance of the differentially expressed miRNAs in gastric cancer. Data are expressed as the means ± standard deviations (SDs). *P < 0.05, **P < 0.01, ***P < 0.001

Back to article page